Medicare Enrolled
Dr. Kendra Zuckerman, M.D.
Rheumatology · Bryn Mawr, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zuckerman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zuckerman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zuckerman
Dr. Kendra Zuckerman is a rheumatology specialist in Bryn Mawr, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zuckerman performed 18,341 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Zuckerman received a total of $12,353 from 57 pharmaceutical and/or device companies across 634 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zuckerman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 32% volume in PA
$12,353 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗18,341
Medicare services
Top 32% in PA for rheumatology
Not available
Unique patients (not deduplicated)
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 12,540 | $18 | $40 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
3,720 | $26 | $115 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
633 | $98 | $218 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
382 | $12 | $50 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
330 | $6 | $113 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
237 | $110 | $322 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
117 | $68 | $147 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
61 | $62 | $170 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
60 | $50 | $170 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
57 | $1 | $11 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
54 | $24 | $73 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
54 | $4 | $15 |
| Injection, methylprednisolone acetate, 40 mg | 32 | $6 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $141 | $264 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $128 | $250 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
16 | $48 | $135 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
21.9% high complexity
73.7% medium
4.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,353
Total received (2018-2024)
Avg $1,765/year across 7 years
Top 25% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
634
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,774
2023
$2,013
2022
$1,702
2021
$1,273
2020
$1,088
2019
$1,671
2018
$1,832
Payments by company (2024)
ABBVIE INC.
$392
ANI Pharmaceuticals, Inc.
$376
Janssen Biotech, Inc.
$215
Amgen Inc.
$186
AstraZeneca Pharmaceuticals LP
$183
UCB, Inc.
$159
Novartis Pharmaceuticals Corporation
$144
Lilly USA, LLC
$142
Fresenius Kabi USA, LLC
$138
Genentech USA, Inc.
$130
Organon Llc
$81
Sandoz Inc.
$76
PFIZER INC.
$70
Alexion Pharmaceuticals, Inc.
$68
Actelion Pharmaceuticals US, Inc.
$51
GENZYME CORPORATION
$49
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
SCILEX PHARMACEUTICALS INC.
$43
GlaxoSmithKline, LLC.
$42
E.R. Squibb & Sons, L.L.C.
$27
Radius Health, Inc.
$26
Aurinia Pharma U.S., Inc.
$22
Kyowa Kirin, Inc.
$20
Mallinckrodt Hospital Products Inc.
$18
Fidia Pharma USA Inc.
$18
Kiniksa Pharmaceuticals International, plc
$17
Alvogen Inc
$17
DePuy Synthes Sales Inc.
$15
Top 3 companies account for 35.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,679
Janssen Biotech, Inc.
$948
UCB, Inc.
$845
Novartis Pharmaceuticals Corporation
$790
ABBVIE INC.
$670
AstraZeneca Pharmaceuticals LP
$590
Genentech USA, Inc.
$585
PFIZER INC.
$543
ANI Pharmaceuticals, Inc.
$538
AbbVie Inc.
$398
Boehringer Ingelheim Pharmaceuticals, Inc.
$390
Lilly USA, LLC
$373
AbbVie, Inc.
$341
E.R. Squibb & Sons, L.L.C.
$313
Alexion Pharmaceuticals, Inc.
$253
Radius Health, Inc.
$242
GlaxoSmithKline, LLC.
$236
GENZYME CORPORATION
$230
Fresenius Kabi USA, LLC
$163
Sandoz Inc.
$145
Celgene Corporation
$144
Actelion Pharmaceuticals US, Inc.
$140
Flexion Therapeutics, Inc.
$129
Mallinckrodt Hospital Products Inc.
$110
Merck Sharp & Dohme Corporation
$104
Aurinia Pharma U.S., Inc.
$102
DePuy Synthes Sales Inc.
$95
Horizon Therapeutics plc
$85
Exeltis, USA Inc.
$84
Organon Llc
$81
Sobi, Inc
$73
Antares Pharma, Inc.
$64
Hikma Pharmaceuticals USA
$63
Bioventus LLC
$63
IBSA Pharma Inc.
$61
Mallinckrodt Enterprises LLC
$61
Cumberland Pharmaceuticals, Inc.
$58
MEDEXUS PHARMA, INC.
$56
Mallinckrodt LLC
$51
Ultragenyx Pharmaceutical Inc.
$50
Organon LLC
$48
SANOFI-AVENTIS U.S. LLC
$48
SCILEX PHARMACEUTICALS INC.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$29
MEDAC PHARMA, INC.
$28
Horizon Pharma plc
$24
Kiniksa Pharmaceuticals, Ltd.
$21
Kyowa Kirin, Inc.
$20
Sebela Pharmaceuticals Inc.
$18
Fidia Pharma USA Inc.
$18
Kiniksa Pharmaceuticals International, plc
$17
Alvogen Inc
$17
Seagen Inc.
$16
SOBI, INC
$16
Celltrion USA Inc.
$14
West-Ward Pharmaceuticals
$14
Ironwood Pharmaceuticals, Inc
$13
Top 3 companies account for 28.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · Cryvista · DUZALLO · Durolane · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUMIZYME · LUPKYNIS · Licart · MONOVISC · Mitigare · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · Prolia · REDITREX · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYNVISC-ONE · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · TUKYSA · Tavneos · Tirosint · Tyenne · Tymlos · UPTRAVI · Uloric · XELJANZ · YUFLYMA · ZTLido · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
178
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zuckerman is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zuckerman experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Zuckerman performed 12,540 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Zuckerman receive payments from pharmaceutical companies?
Yes. Dr. Zuckerman received a total of $12,353 from 57 companies across 634 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zuckerman's costs compare to other rheumatologists in Bryn Mawr?
Dr. Zuckerman's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zuckerman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Bryn Mawr
Browse rheumatologists in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in PA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in PA
Which PA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology